Leukocyte infiltration in atherosclerosis has been extensively investigated by using histological techniques on fixed tissues. In this study, intravital microscopic observations of leukocyte recruitment in the aorta of atherosclerotic mice were performed. Interactions between leukocytes and atherosclerotic endothelium were highly transient, thereby limiting the ability for rolling leukocytes to firmly adhere. Leukocyte rolling was abolished by function inhibition of P-selectin (P<0.001, n‫,)8؍‬ whereas antibody blockage of E-selectin (n‫)01؍‬ decreased rolling leukocyte flux to 51 ؎ 9.9% (mean؎SE, P<0.01) and increased leukocyte rolling velocity to 162 ؎ 18% (P<0.01) of pretreatment values. Notably, function inhibition of the integrin ␣ 4 subunit (n‫)5؍‬ had no effect on rolling flux (107؎25%, P‫)287.0؍‬ or rolling velocity (89؎6.1%, P‫,)741.0؍‬ despite endothelial expression of vascular cell adhesion molecule 1 (VCAM-1). Leukocytes interacting with atherosclerotic endothelium were predominantly neutrophils, because treatment with antineutrophil serum decreased rolling and neutrophil counts in peripheral blood to the same extent. In conclusion, we present the first direct observations of atherosclerosis in vivo. We show that transient dynamics of leukocyte-endothelium interactions are important regulators of arterial leukocyte recruitment and that leukocyte rolling in atherosclerosis is critically dependent on the endothelial selectins. This experimental technique and the data presented introduce a novel perspective for the study of pathophysiological events involved in large-vessel disease.-Eriksson, E. E., Xie, X., Werr, J., Thoren, P., Lindbom, L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 15, 1149 -1157 (2001) 
Atherosclerosis develops over years and decades. However, many of the mechanisms responsible for initiation, growth, and acute symptoms involved in atherosclerosis are dynamic events that may occur within a much shorter time frame. Still, most studies of the pathogenesis of atherosclerosis have been performed by using histological techniques on fixed tissues, techniques with limited ability to reflect dynamic events. Thus, in the study of atherosclerosis, there may often be a discrepancy between the pathophysiological mechanisms and the experimental techniques used.
An important event in atherogenesis and in the destabilization of developed plaque is the recruitment of leukocytes to the arterial wall (1, 2) . The process of leukocyte recruitment in atherosclerosis is believed to be mediated by sequential steps of leukocyte-endothelium interactions similar to those occurring in postcapillary venules in inflammation. In venules, such interactions are mediated by various cell adhesion molecules (CAMs) on leukocytes and on endothelial cells (3) . Initial leukocyte capture and rolling along the endothelium are mediated primarily by the selectin family of CAMs and their counterreceptors (4, 5) , whereas firm adhesion to the endothelium is mediated primarily by integrin receptors on leukocytes interacting with their endothelial ligands (6) . In contrast to the relatively well known mechanisms mediating these processes in inflammation, the cellular and molecular events involved in leukocyte recruitment in atherosclerosis remain largely unclear. Special interest has focused on vascular cell adhesion molecule 1 (VCAM-1), because it is up-regulated on arterial endothelium after atherogenic stimuli (7, 8) and because it preferentially mediates recruitment of mononuclear leukocytes such as monocytes and T lymphocytes (9) , subtypes of leukocytes that are present in atherosclerotic lesions (10, 11) . However, studies indicate roles in atherosclerosis for other CAMs as well (9, (12) (13) (14) .
In the present study, we used a novel intravital microscopic technique (15) to study the dynamics of leukocyte recruitment in the aorta of atherosclerotic mice in vivo. We found that leukocyte tethering, rolling, and firm adhesion occurred and could be observed in atherosclerosis, whereas leukocyte-endothelium interactions were virtually absent in healthy mice of similar age. Interactions on atherosclerotic endothelium were transient, and the efficiency of rolling leukocytes to initiate firm adhesion was low. All rolling interactions depended critically on the endothelial selectins. These data unravel specific features of leukocyte-endothelium interactions in atherosclerosis previously not accessible to experimental investigation.
MATERIALS AND METHODS

Animals
Male ApoE/LDL receptor double-knockout mice (ApoE 0 LDLR 0 ) and ApoE single knockout mice (ApoE 0 ) of either sex as well as control C57BL/6 mice were obtained from M&B, Ry, Denmark. C57BL/6 mice were fed with standard diet (Beekay Feeds, B&K Universal, Stockholm, Sweden), whereas atherosclerosis-prone mice from 8 wk of age were fed with Western diet (WD) containing 0.15% cholesterol (Analyzen, Odal, Sweden). Food and water were provided ad libitum. The experiments were approved by the regional ethical committee for animal experimentation.
Experimental procedure
Mice were anesthetized by inhalation of 2% isoflurane in 40% O 2 , and catheters were placed in the left carotid artery and in the left jugular vein. Blood pressure was measured through the carotid catheter connected to a pressure transducer and a Grass amplifier. An intravenous (i.v.) infusion of bicarbonate-buffered glucose (0.4 ml/h) was used to maintain normal acid-base balance. Rectal temperature was kept at 37°C with a heating pad and an infrared heat lamp. The exposed tissue was superfused with a thermostated (37°C) bicarbonatebuffered saline solution equilibrated with 5% CO 2 in nitrogen to maintain physiological pH or was covered with a physiologically buffered hyaluronic acid solution (Healon, 14 mg/ml, Pharmacia-Upjohn, Uppsala, Sweden). All parameters were recorded via computer using Grass Polyview software and stored for later analysis. Serial blood samples (10 l) were taken through the carotid catheter and analyzed for white blood cells (WBCs) in a Bü rker chamber.
Surgical procedure
The abdomen was opened through a midline incision and the intestines were retracted and kept moist during the experiment. The aorta was exposed and, without direct manipulation of the vessel, was separated from the vena cava for a distance of 2-3 mm immediately inferior of the renal arteries. The mouse was placed under the microscope, and an ultrasonic flow probe connected to a flowmeter (Transonic T-106 flowmeter, 0.7 V flow probe, sample rate: 200/s) was placed around the artery. Direct intravital microscopic observations were performed on the abdominal aorta at least 4 -5 mm downstream of the flow probe.
Intravital microscopy
Microscopic observations were made by using an intravital microscope (Leitz Biomed, Wetzlar, Germany) with a water immersion objective (Leitz SW 25ϫ). Epi-illumination fluorescence microscopy (Leitz Ploem-o-pac, filter block M2 illuminated by a cooled infrared filtered lamp [Osram HBO 200W/4]) was started 2 min after labeling of circulating leukocytes with an i.v. injection of rhodamine 6G (0.3 mg/ml, 0.67 mg/kg). Images were televised and recorded on videotape by using a light-sensitive Panasonic WV-1900 video camera.
Analysis of in vivo experiments
In the aorta and in the iliac arteries, rolling and adhering leukocytes were clearly visualized on the anterior half of the vessels facing the objective. However, on severe atherosclerotic lesions visualization was difficult because of the increased thickness of the arterial wall. Rolling leukocyte flux was determined as the number of rolling leukocytes passing a reference line perpendicular to blood flow. Leukocyte rolling velocity was determined as the mean velocity of individual rolling leukocytes. Leukocyte-endothelium contact time and leukocyte rolling distance were determined as the respective time and distance individual leukocytes were in contact with, and rolled along, the endothelium. Adhesion efficiency was determined as the percentage of rolling leukocytes that went from rolling to firm adhesion.
Scanning electron microscopy
Animals were perfusion fixed through the left ventricle with 2.5% glutaraldehyde in phosphate buffer (20 min, 100 mmHg) with outflow through severed jugular veins. The aorta was excised, dissected free from perivascular tissue, opened longitudinally, and attached en face on glass slides (Superfrost Plus Gold) using superglue. The specimens were then dehydrated in increasing concentrations of ethanol and Freon 113 and finally through critical point dehydration with CO 2 . After gold sputter coating, the aortas were examined in a scanning electron microscope (Philips sem 515).
Immunofluorescence microscopy
Mice were perfusion fixed through the left ventricle with 1% paraformaldehyde in phosphate buffer (10 min, 100 mmHg). The aorta was excised, dissected free from perivascular tissue, kept in fixative for 1-2 h at 4°C, opened longitudinally, cut in 1-cm segments, and washed in PBS followed by blockage of unspecific binding with 10% rabbit serum in PBS for 30 min at 4°C. The vessels were kept overnight in primary antibody or irrelevant isotype-matched control antibody (10 g/ml), after which they were washed, incubated with fluorescein isothiocyanate (FITC)-conjugated rabbit F(abЈ) 2 anti-rat immunoglobulin G (IgG) (dilution 1:50), washed, mounted en face on glass slides, and viewed in a laser scanning confocal microscope (Insight Plus, Meridian Instruments, Okemos, MI) under normal transmitted and laser-emitted fluorescent light.
Antibodies and reagents
The antibodies used in vivo in this study were monoclonal antibody (mAb) RB40.34 against mouse P-selectin (30 g/ mouse; Pharmingen, San Diego, CA), mAb 9A9 against mouse E-selectin (30 g/mouse; a kind gift from B. A. Wolitzky, Hoffmann-La Roche, Nutley, NJ), mAb R1-2 against mouse integrin ␣ 4 subunit (150 g/mouse; Pharmingen), and the isotype-matched control mAb R3-34 (60 g/ mouse; Pharmingen). All antibodies used in vivo were previously shown to be specific for and block the function of their respective CAMs. Antibodies used for immunofluorescence microscopy were mAb RB40.34, mAb R3-34, and mAb MK2.7 against mouse VCAM-1 (Serotec, Oxford, U.K.). FITC-conjugated rabbit F(abЈ) 2 anti-rat IgG came from Serotec. Rabbit anti-mouse antineutrophil serum (ANS; 25 l/mouse) came from Inter-Cell Technologies, Hopewell, NJ. Rhodamine 6G came from Sigma Chemical, St. Louis, MO.
Statistical analysis
The data represent the mean Ϯ se of measurements obtained in the indicated number of experiments. Statistical analysis was performed using t test, the Mann-Whitney rank sum test, the paired t test, and the Wilcoxon signed rank test for paired samples. Statistical significance was set at P Ͻ 0.05. In figures, *, **, and *** denote differences from control values by significance levels of P Ͻ 0.05, P Ͻ 0.01, and P Ͻ 0.001, respectively.
RESULTS
All mice were healthy before the experiments. Blood flow in the aorta ranged between 0.6 and 2.5 ml/min, and no differences in blood flow among different strains of mice were detected. Blood pressure was measured at the end of the experiments and ranged between 60 and 100 mmHg. The WBC count was 4.7 Ϯ 0.7 ϫ 10 6 cells/ml (polymorphonuclear leukocytes: 48Ϯ3.8%, mononuclear leukocytes: 52Ϯ3.8%) and was not altered by any of the antibody treatments. In intravital microscopy experiments, arterial lesions were detected in ApoE 0 and ApoE 0 LDLR 0 mice. In histological sections, these areas showed characteristics typical of atherosclerosis (not shown). In ApoE 0 mice, early lesions could appear in the abdominal aorta below the renal arteries after 4 -5 months with use of the WD, whereas in ApoE 0 LDLR 0 mice, such lesions could be found after only 2-3 months. In both strains, plaque development in the abdominal aorta was delayed and limited compared with the extensive lesion formation seen in large arteries in the thorax and neck.
Leukocyte-endothelium interactions occur and can be observed in atherosclerosis in vivo
In 5-to 15-month-old control C57BL/6 mice (nϭ24), leukocyte-endothelium interactions were absent except in four mice in which minimal rolling of leukocytes was observed in the aortic bifurcation. In atherosclerotic mice, leukocyte-endothelium interactions were not observed in animals that did not show signs of arterial lesions. However, when lesions were present, leukocyte rolling was observed in 45 of 64 mice (70%, a similar percentage in both atherosclerotic strains). The average number of rolling leukocytes in atherosclerotic mice was 5.8 Ϯ 1.8 and 14 Ϯ 3.2 cells/min in ApoE 0 (nϭ13) and ApoE 0 LDLR 0 (nϭ51) animals, respectively (Pϭ0.117, range: 0 -92 cells/min, Fig. 1 ). Stereoscopic microscopic, intravital microscopic, and scanning electron microscopic appearances of an atherosclerotic plaque where leukocyte rolling was observed are shown in Fig. 2A-C .
In early atherosclerotic lesions, leukocyte-endothelium interactions were detected on the entire injured area; in severe lesions, however, interactions were typically observed in the periphery of plaque, primarily downstream and along the sides of lesions. On severe plaque, most rolling leukocytes were also captured in the periphery of those lesions. Thus, it seems that both tethering and rolling of leukocytes in developed atherosclerosis occur preferentially at the border between the plaque and the parts of the arterial wall less affected by lesion formation. In areas of the aorta distant from plaque and unaffected by lesions, interactions were rare. However, in a few mice such interactions were observed, possibly reflecting early lesion development.
Leukocyte rolling in atherosclerosis does not occur in clusters and is not mediated by platelets adherent to the endothelium
Leukocytes rolling along the endothelium in atherosclerotic arteries were observed as single rolling cells. Clusters of leukocytes and platelets, similar to what have previously been described in systems in which platelets are important in leukocyte recruitment (16, 17) , were not detected. To further investigate the potential role of platelets in leukocyte-endothelium interactions in atherosclerosis, scanning electron microscopy was used on arteries in which leukocyte rolling had previously been observed in vivo (Fig. 2C) . Atherosclerotic plaques were observed as elevated areas in the arterial wall and the endothelial lining was in each specimen intact (nϭ4). Adherent leukocytes were found on and in the periphery of plaque. Platelet adhesion was rare.
Leukocyte-endothelium interactions in atherosclerosis are transient and leukocyte adhesion efficiency is low
The characteristics of leukocyte-endothelium interactions in atherosclerosis were investigated and compared with previous data from cytokine-treated venules (18) and cytokine-treated mouse aorta (15) . Data are shown in Table 1 . The typical cumulative rolling distance as a function of time is shown in Fig. 3 . Leukocyte rolling in atherosclerosis occurred in small areas in the periphery of atherosclerotic lesions, resulting in a short leukocyte rolling distance. This should be compared with a fivefold longer leukocyte rolling distance previously observed in cytokine-stimulated venules. The difference in leukocyte-endothelium contact time between atherosclerosis and cytokine-treated venules was even more pronounced, because of a large difference in leukocyte rolling velocity. The differences in the characteristics of leukocyte-endothelium interactions between atherosclerosis and inflamed venules is likely partly due to differences in the local hemodynamics, inasmuch as wall shear rate is higher in arteries than in venular systems. This result is supported by previous data demonstrating that wall shear rate strongly influences leukocyte rolling in various vessel types (4, 15, 19) . In accordance with the transient dynamics of interactions, adhesion efficiency of rolling leukocytes in atherosclerosis was found to be low compared with that in venules. During a total time of 90 min of intravital observations, 1267 leukocytes were observed rolling on atherosclerotic endothelium. Among these 1267 leukocytes, only 4 went from rolling to firm adhesion (0.3%); in contrast, 91% of leukocytes rolling in inflamed venules eventually adhere. In cytokinetreated aorta, leukocyte rolling velocity was quite similar to that in atherosclerosis. However, rolling distance and leukocyte-endothelium contact time were greater, reflecting a more widespread expression of CAMs compared with that in atherosclerotic endothelium. Likewise, the adhesion efficiency of rolling leukocytes was higher in cytokine-treated aorta at a magnitude that correlated with the differences in rolling distance and contact time. This result may indicate that the higher adhesion efficiency in cytokine-treated aorta than in atherosclerosis was due to the longer time that leukocytes were in contact with the endothelium and, accordingly, a longer exposure to chemoattractants present in the arterial wall. Thus, transit time for leukocytes rolling along the endothelium may be an important parameter influencing the induction of firm leukocyte adhesion in arteries and atherosclerosis, as previously shown in venules (20) . This may be a critical factor in limiting leukocyte recruitment in atherogenesis.
Leukocyte rolling in atherosclerosis depends on the endothelial selectins
The molecular basis for leukocyte rolling in atherosclerotic mice was studied by using function-blocking antibodies against various CAMs. Antibodies were given as i.v. injections in 60 -70 l of PBS. Blood flow in the aorta was stable during the experiments. Antibody experiments were primarily performed in ApoE 0 LDLR 0 mice fed the WD for 5-6 months. At this time, the progression of atherosclerosis in the abdominal aorta below the renal arteries was moderate, and lesions were visible in 30 of 44 mice (68%). Additional experiments with selectin-blocking antibodies were performed in ApoE 0 mice at various ages (5-18 months) in which atherosclerotic lesion formation ranged from minimal progression up to almost complete coverage of the abdominal aorta by plaques. Notably, the adhesion molecules involved in leukocyte rolling were the same in all stages of lesions and in all age groups of both strains; therefore, data for selectin-blocking antibodies presented in Fig. 4 Furthermore, function inhibition of P-selectin after treatment with antibodies blocking the function of E-selectin (nϭ6) or integrin ␣ 4 (nϭ5) again almost abolished leukocyte rolling (PϽ0.001). To further investigate the importance of P-selectin in leukocyte rolling in atherosclerosis, the time of observation after treatment with function-blocking antibodies against this adhesion molecule was extended. No leukocytes interacted with the endothelium during 130 min of observation after function inhibition of P-selectin alone (nϭ8). Moreover, during 65 min of observation after simultaneous blockage of P-and E-selectin (nϭ6), only one (1) leukocyte interacted transiently (Ͻ0.5 s) with the aortic endothelium. Furthermore, in four of five mice treated with an antibody against the integrin ␣ 4 , additional function inhibition of P-selectin abolished interactions for a total time of 45 min, regardless of the result that the integrin ␣ 4 antibody was without obvious effect. However, in one ApoE 0 LDLR 0 mouse treated with the antibody against integrin ␣ 4 , function inhibition of P-selectin was not sufficient to abrogate leukocyte-endothelium interactions, and a rolling flux of 0.67 cell/min remained after antibody treatment. These remaining interactions were abolished by function inhibition of E-selectin.
The qualitative appearance of leukocyte-endothelium interactions after antibody treatment was also investigated. Leukocyte-endothelium contact time was decreased by function inhibition of E-selectin ( Fig. 4C ). No effect on leukocyte rolling velocity was observed either after treatment with integrin ␣ 4 (mean velocity: 89Ϯ6.1%, Pϭ0.147; individual leukocytes: 88Ϯ5.1%, Pϭ0.139; nϭ5) or control antibodies (mean velocity: 100Ϯ17%, Pϭ0.980; individual leukocytes: 105Ϯ9.9%, Pϭ0.662; nϭ5). It is important to note that the E-selectin antibody (9A9) proved not to influence P-selectin-dependent interactions and E-selectin-independent interactions inasmuch as treatment with 9A9 antibody did not alter rolling flux or rolling velocity either in traumainduced rolling in the mouse cremaster muscle (rolling flux: 108Ϯ21% of rolling flux before antibody treatment, Pϭ0.502; rolling velocity: 107Ϯ12, Pϭ0.542; nϭ3) or in the aorta of C57BL/6 mice when rolling was rapidly up-regulated by topical application of irritant (rolling flux: 95Ϯ2.5%, Pϭ0.184; rolling velocity: 85Ϯ8.1%, Pϭ0.198; nϭ3) . Taken together, the data indicate that capture and rolling of leukocytes in atherosclerosis depend almost totally on the endothelial selectins.
Neutrophils roll along atherosclerotic endothelium in vivo
Because P-and E-selectin are known to predominantly mediate rolling of neutrophils in inflamed venules (21) , it was of interest to investigate whether neutrophils could contribute to selectin-dependent leukocyte rolling in atherosclerosis as well. In atherosclerotic mice in which leukocyte rolling was observed (nϭ5), ANS was administered acutely through an i.v. injection. Results are shown in Fig. 5 . ANS reduced the systemic granulocyte count and mononuclear cell count to 21 Ϯ 3.7% and 61 Ϯ 11% of the counts before ANS treatment, respectively. Leukocyte rolling decreased at the same time to 18 Ϯ 5.3%, suggesting that a majority of the leukocytes rolling along atherosclerotic endothelium were neutrophils. 
Expression of CAMs on atherosclerotic endothelium
To further characterize the CAMs responsible for leukocyte rolling in atherosclerosis, we used immunofluorescence microscopy to analyze atherosclerotic aortas in which leukocyte rolling had been observed in vivo. Of three experiments, strong expression of P-selectin was found in two aortas and weak expression was found in one aorta at these specific sites (Fig. 6A) . In areas where no leukocyte rolling had been observed, staining was negative. Positive staining for VCAM-1 was regularly found in the periphery of plaque, as described previously (22) (Fig. 6B) , whereas no positive staining was detected using an isotype-matched control antibody. Because leukocyte rolling and P-selectin expression were found mainly in the periphery of lesions, Pselectin seems to colocalize with the typical expression pattern of VCAM-1. As in previous studies (22), we were not able to safely stain E-selectin on arterial endothelium, possibly because of limited expression of this CAM. This result agrees with previous data from the microcirculation where E-selectin has eluded staining in arterioles treated with mouse tumor necrosis factor ␣ (TNF-␣) (23) despite a clear-cut effect of this CAM in arteriolar leukocyte-endothelium interactions in vivo (19) . Nonetheless, in vivo data (this paper and refs 13 and 14) strongly indicate that E-selectin is expressed and plays an important role in leukocyte recruitment in atherogenesis.
DISCUSSION
The dynamic processes of leukocyte recruitment in atherosclerosis have for long remained to be elucidated. In this study, we used intravital microscopy to directly examine leukocyte-endothelium interactions in vivo in the aorta of atherosclerotic mice. The data show that leukocyte recruitment in atherogenesis is truly a dynamic event and suggest that aspects of the pathophysiology of atherosclerosis may, with clear advantage, be investigated through direct observations in real time. Thus, the approach presented here adds to classical experimental models for studies of atherosclerosis and opens new prospects in this field of research.
Previous studies investigating the mechanisms of leukocyte recruitment in atherosclerosis have detected different CAMs expressed on arterial endothelium and have revealed the presence of adherent and transmigrated leukocytes. However, it has not been clearly shown whether the multistep pathway responsible for leukocyte recruitment in tissue inflammation is also critical in atherosclerosis. Thus, the specific roles for different CAMs found on arterial endothelium in arterial leukocyte recruitment remain unclear. In this study, we found that leukocyte rolling and firm adhesion occur in various stages of atherosclerosis, thus demonstrating that leukocyte recruitment on atherosclerotic lesions takes place in a multistep fashion. Lesions in which interactions were investigated ranged from early lesions to developed fibrous plaque. On developed lesions, leukocyte-endothelium interactions were observed primarily in the periphery of plaque, corresponding to preferential CAM expression in these areas (this paper and ref 22) .
Leukocyte-endothelium interactions in atherosclerosis are transient compared with those occurring in venules at sites of inflammation. Leukocyte-endothelium contact time and leukocyte rolling distance are lower and leukocyte rolling velocity is higher than those in venules. These parameters are likely influenced by hemodynamic conditions, with high shear stressing the molecular bonds of leukocyte-endothelium interactions in arteries. Conceivably, these transient interactions in atherosclerosis and the consequent brief exposure of rolling leukocytes to chemoattractants present in plaque restrict the efficiency of leukocytes rolling along atherosclerotic endothelium to initiate firm adhesion. However, because atherosclerosis in ApoE 0 and ApoE 0 LDLR 0 mice is a process that progresses over months and years, the conspicuously low number of leukocytes that firmly adhere is likely sufficient for lesion development. In fact, the low adhesion efficiency may be a rate-limiting step in the progress of atherogenesis, and small changes in the absolute number of recruited leukocytes may lead to significant changes in the development of lesions. Accordingly, the levels of chemoattractants present in the arterial wall, potentially influencing adhesion efficiency, may be important in regulation of recruitment of leukocytes and hence in the progression of the atherosclerotic disease.
Initial attachment and rolling of leukocytes on atherosclerotic endothelium depend critically on P-selectin. The importance of P-selectin in arterial leukocyteendothelium interactions is supported by data from the cytokine-treated mouse aorta where leukocyte rolling was dramatically decreased, although not abolished, by P-selectin blockage (15) . In addition to P-selectin, E-selectin influences rolling interactions, inasmuch as function inhibition of this CAM increases rolling velocity and decreases leukocyte-endothelium contact time. This result indicates that E-selectin stabilizes and slows down leukocyte rolling in atherosclerosis and thereby, as previously shown in venules (20) , increases the tendency for firm adhesion. Evidently, the endothelial selectins mediate virtually all leukocyte rolling in atherosclerosis, and because no leukocytes firmly adhered without initial rolling along the endothelium, the endothelial selectins seem to play critical roles in leukocyte recruitment in atherosclerosis. In addition, in vivo experiments and scanning electron microscopy clearly show that leukocyte-endothelium interactions in atherosclerosis occur on an intact endothelial lining and that there is no obvious role for platelets in this process. Thus, the molecular mechanisms responsible for leukocyte rolling in atherosclerosis are similar to the mechanisms previously shown in cytokine-challenged mice (15) and suggest that cytokines present in atherosclerosis (24, 25) are important in inducing expression of CAMs and thereby in the recruitment of leukocytes.
In contrast to previous studies supporting a role for VCAM-1 in leukocyte recruitment in atherosclerosis, our data suggest that the integrin ␣ 4 /VCAM-1 pathway may not mediate initial attachment or rolling of leukocytes regardless of expression of VCAM-1 on arterial endothelium. However, this pathway may still influence rolling of certain leukocyte subclasses, such as monocytes and T lymphocytes, which cannot be discriminated from other subclasses in intravital microscopy experiments in which intravascular labeling of leukocytes is used. Roles for integrin ␣ 4 and VCAM-1 in leukocyte rolling in atherosclerosis are supported by findings that these CAMs can influence rolling and adhesion in carotid arteries from ApoE 0 mice perfused with monocytic cell lines (26) . Moreover, integrin ␣ 4 or VCAM-1 could be important in firm adhesion and transmigration.
Results from the present study strongly indicate that tethering and rolling of all types of leukocytes interacting with atherosclerotic endothelium depend critically on the endothelial selectins. These roles for the endothelial selectins explain previous findings of delayed lesion development in atherosclerotic mice lacking P-selectin, E-selectin, or P-and E-selectin in combination (13, 14) .
In other vascular systems, such as venules (21) and cytokine-treated arterioles (19) and arteries (E. E. Eriksson et al., unpublished data), the endothelial selectins primarily mediate interactions with neutrophils. Interestingly, we found that this is most likely also true in atherosclerosis, a fact that could explain the lack of effect of function inhibition of the integrin ␣ 4 , a CAM that is predominantly expressed on mononuclear leukocytes (27) . However, in the literature, neutrophils are rarely mentioned in the context of atherosclerosis. Nonetheless, because leukocyte-endothelium interactions alone may influence functions of both leukocytes and endothelial cells by signaling via CAMs (28 -30), we predict that neutrophils could play roles in atherogenesis despite the fact that they may not be a prominent histological feature of atherosclerotic lesions. Moreover, a few studies suggest that small numbers of neutrophils, neutrophil-specific substances, and chemoattractants with the ability to enhance recruitment of neutrophils may be found in atherosclerotic lesions (31) (32) (33) . Given the limited life span of neutrophils in inflamed tissue (34) , even small numbers of neutrophils detected in histological sections may reflect significant invasion of these cells in plaque in vivo. Thus, even though the present study does not specifically identify which CAMs mediate recruitment of monocytes and T lymphocytes into atherosclerotic lesions, these first dynamic studies of leukocytes interacting with atherosclerotic endothelium indicate that leukocyte subclasses other than mononuclear cells may be involved in the pathophysiology of this disease. Although roles for such leukocytes in atherogenesis are at this stage hypothetical, the issue of transiently interacting leukocytes in atherosclerosis clearly requires further investigation.
In summary, we have performed, for the first time, direct observations of leukocyte recruitment in atherosclerosis in vivo. Using this technique, we establish that aspects of the dynamic cellular mechanisms in atherosclerosis can be observed and investigated in an in vivo situation. The data reveal that leukocyte-endothelium interactions in atherosclerosis are transient compared with those occurring in tissue inflammation, thereby limiting the capability of leukocytes to firmly adhere and be recruited to atherosclerotic lesions. Moreover, we show that initial attachment and rolling of leukocytes in atherosclerosis are critically dependent on the endothelial selectins, results that together with other data also raise questions about the potential involvement of leukocytes other than monocytes and T lymphocytes in this disease. This new technique and the data presented reveal the feasibility of dynamic observations of atherosclerosis in vivo. What is more, new opportunities for investigating the acute and chronic events of large-vessel disease such as balloon injury, plaque rupture, and vascular thrombosis now evolve.
